B · Normal
[Swedish Nanexa’s stock price rose 150% after reaching a global licensing agreement with Novo Nordisk] On September 25, Sweden’s Nanexa’s stock price rose 150% after reaching a global licensing agreement with Novo Nordisk. Previously, Novo Nordisk and Swedish Nanexa signed a drug technology cooperation agreement worth 1.165 billion euros.
Global market intelligence 🕐 2026-09-25 15:10

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet